Global Uterine Fibroid Embolization Device Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Uterine Fibroid Embolization Device Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Uterine Fibroid Embolization Device by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Uterine Fibroid Embolization Device by Country/Region, 2017, 2022 & 2028

2.2 Uterine Fibroid Embolization Device Segment by Type

2.2.1 Gelatin Sponge

2.2.2 Polyvinyl Alcohol ( PVA ) Particles

2.2.3 Trisacryl Gelatin Microspheres ( TAGM )

2.2.4 Polymethyl Methacrylate ( PMMA ) Microspheres

2.3 Uterine Fibroid Embolization Device Sales by Type

2.3.1 Global Uterine Fibroid Embolization Device Sales Market Share by Type (2017-2022)

2.3.2 Global Uterine Fibroid Embolization Device Revenue and Market Share by Type (2017-2022)

2.3.3 Global Uterine Fibroid Embolization Device Sale Price by Type (2017-2022)

2.4 Uterine Fibroid Embolization Device Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.5 Uterine Fibroid Embolization Device Sales by Application

2.5.1 Global Uterine Fibroid Embolization Device Sale Market Share by Application (2017-2022)

2.5.2 Global Uterine Fibroid Embolization Device Revenue and Market Share by Application (2017-2022)

2.5.3 Global Uterine Fibroid Embolization Device Sale Price by Application (2017-2022)

3 Global Uterine Fibroid Embolization Device by Company

3.1 Global Uterine Fibroid Embolization Device Breakdown Data by Company

3.1.1 Global Uterine Fibroid Embolization Device Annual Sales by Company (2020-2022)

3.1.2 Global Uterine Fibroid Embolization Device Sales Market Share by Company (2020-2022)

3.2 Global Uterine Fibroid Embolization Device Annual Revenue by Company (2020-2022)

3.2.1 Global Uterine Fibroid Embolization Device Revenue by Company (2020-2022)

3.2.2 Global Uterine Fibroid Embolization Device Revenue Market Share by Company (2020-2022)

3.3 Global Uterine Fibroid Embolization Device Sale Price by Company

3.4 Key Manufacturers Uterine Fibroid Embolization Device Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Uterine Fibroid Embolization Device Product Location Distribution

3.4.2 Players Uterine Fibroid Embolization Device Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Uterine Fibroid Embolization Device by Geographic Region

4.1 World Historic Uterine Fibroid Embolization Device Market Size by Geographic Region (2017-2022)

4.1.1 Global Uterine Fibroid Embolization Device Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Uterine Fibroid Embolization Device Annual Revenue by Geographic Region

4.2 World Historic Uterine Fibroid Embolization Device Market Size by Country/Region (2017-2022)

4.2.1 Global Uterine Fibroid Embolization Device Annual Sales by Country/Region (2017-2022)

4.2.2 Global Uterine Fibroid Embolization Device Annual Revenue by Country/Region

4.3 Americas Uterine Fibroid Embolization Device Sales Growth

4.4 APAC Uterine Fibroid Embolization Device Sales Growth

4.5 Europe Uterine Fibroid Embolization Device Sales Growth

4.6 Middle East & Africa Uterine Fibroid Embolization Device Sales Growth

5 Americas

5.1 Americas Uterine Fibroid Embolization Device Sales by Country

5.1.1 Americas Uterine Fibroid Embolization Device Sales by Country (2017-2022)

5.1.2 Americas Uterine Fibroid Embolization Device Revenue by Country (2017-2022)

5.2 Americas Uterine Fibroid Embolization Device Sales by Type

5.3 Americas Uterine Fibroid Embolization Device Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Uterine Fibroid Embolization Device Sales by Region

6.1.1 APAC Uterine Fibroid Embolization Device Sales by Region (2017-2022)

6.1.2 APAC Uterine Fibroid Embolization Device Revenue by Region (2017-2022)

6.2 APAC Uterine Fibroid Embolization Device Sales by Type

6.3 APAC Uterine Fibroid Embolization Device Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Uterine Fibroid Embolization Device by Country

7.1.1 Europe Uterine Fibroid Embolization Device Sales by Country (2017-2022)

7.1.2 Europe Uterine Fibroid Embolization Device Revenue by Country (2017-2022)

7.2 Europe Uterine Fibroid Embolization Device Sales by Type

7.3 Europe Uterine Fibroid Embolization Device Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Uterine Fibroid Embolization Device by Country

8.1.1 Middle East & Africa Uterine Fibroid Embolization Device Sales by Country (2017-2022)

8.1.2 Middle East & Africa Uterine Fibroid Embolization Device Revenue by Country (2017-2022)

8.2 Middle East & Africa Uterine Fibroid Embolization Device Sales by Type

8.3 Middle East & Africa Uterine Fibroid Embolization Device Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Uterine Fibroid Embolization Device

10.3 Manufacturing Process Analysis of Uterine Fibroid Embolization Device

10.4 Industry Chain Structure of Uterine Fibroid Embolization Device

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Uterine Fibroid Embolization Device Distributors

11.3 Uterine Fibroid Embolization Device Customer

12 World Forecast Review for Uterine Fibroid Embolization Device by Geographic Region

12.1 Global Uterine Fibroid Embolization Device Market Size Forecast by Region

12.1.1 Global Uterine Fibroid Embolization Device Forecast by Region (2023-2028)

12.1.2 Global Uterine Fibroid Embolization Device Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Uterine Fibroid Embolization Device Forecast by Type

12.7 Global Uterine Fibroid Embolization Device Forecast by Application

13 Key Players Analysis

13.1 Boston Scientific Corporation

13.1.1 Boston Scientific Corporation Company Information

13.1.2 Boston Scientific Corporation Uterine Fibroid Embolization Device Product Offered

13.1.3 Boston Scientific Corporation Uterine Fibroid Embolization Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Boston Scientific Corporation Main Business Overview

13.1.5 Boston Scientific Corporation Latest Developments

13.2 Merit Medical Systems

13.2.1 Merit Medical Systems Company Information

13.2.2 Merit Medical Systems Uterine Fibroid Embolization Device Product Offered

13.2.3 Merit Medical Systems Uterine Fibroid Embolization Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merit Medical Systems Main Business Overview

13.2.5 Merit Medical Systems Latest Developments

13.3 BioSpace

13.3.1 BioSpace Company Information

13.3.2 BioSpace Uterine Fibroid Embolization Device Product Offered

13.3.3 BioSpace Uterine Fibroid Embolization Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 BioSpace Main Business Overview

13.3.5 BioSpace Latest Developments

13.4 Hologic, Inc.

13.4.1 Hologic, Inc. Company Information

13.4.2 Hologic, Inc. Uterine Fibroid Embolization Device Product Offered

13.4.3 Hologic, Inc. Uterine Fibroid Embolization Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Hologic, Inc. Main Business Overview

13.4.5 Hologic, Inc. Latest Developments

13.5 Cook Medical

13.5.1 Cook Medical Company Information

13.5.2 Cook Medical Uterine Fibroid Embolization Device Product Offered

13.5.3 Cook Medical Uterine Fibroid Embolization Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Cook Medical Main Business Overview

13.5.5 Cook Medical Latest Developments

13.6 Ferring B.V.

13.6.1 Ferring B.V. Company Information

13.6.2 Ferring B.V. Uterine Fibroid Embolization Device Product Offered

13.6.3 Ferring B.V. Uterine Fibroid Embolization Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Ferring B.V. Main Business Overview

13.6.5 Ferring B.V. Latest Developments

13.7 Smith+Nephew

13.7.1 Smith+Nephew Company Information

13.7.2 Smith+Nephew Uterine Fibroid Embolization Device Product Offered

13.7.3 Smith+Nephew Uterine Fibroid Embolization Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Smith+Nephew Main Business Overview

13.7.5 Smith+Nephew Latest Developments

13.8 CooperSurgical, Inc.

13.8.1 CooperSurgical, Inc. Company Information

13.8.2 CooperSurgical, Inc. Uterine Fibroid Embolization Device Product Offered

13.8.3 CooperSurgical, Inc. Uterine Fibroid Embolization Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 CooperSurgical, Inc. Main Business Overview

13.8.5 CooperSurgical, Inc. Latest Developments

13.9 Aetna Better Health of Pennsylvania

13.9.1 Aetna Better Health of Pennsylvania Company Information

13.9.2 Aetna Better Health of Pennsylvania Uterine Fibroid Embolization Device Product Offered

13.9.3 Aetna Better Health of Pennsylvania Uterine Fibroid Embolization Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Aetna Better Health of Pennsylvania Main Business Overview

13.9.5 Aetna Better Health of Pennsylvania Latest Developments

13.10 Ethicon US, LLC

13.10.1 Ethicon US, LLC Company Information

13.10.2 Ethicon US, LLC Uterine Fibroid Embolization Device Product Offered

13.10.3 Ethicon US, LLC Uterine Fibroid Embolization Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Ethicon US, LLC Main Business Overview

13.10.5 Ethicon US, LLC Latest Developments

13.11 Olympus America

13.11.1 Olympus America Company Information

13.11.2 Olympus America Uterine Fibroid Embolization Device Product Offered

13.11.3 Olympus America Uterine Fibroid Embolization Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Olympus America Main Business Overview

13.11.5 Olympus America Latest Developments

13.12 Stryker

13.12.1 Stryker Company Information

13.12.2 Stryker Uterine Fibroid Embolization Device Product Offered

13.12.3 Stryker Uterine Fibroid Embolization Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Stryker Main Business Overview

13.12.5 Stryker Latest Developments

13.13 Astellas Pharma

13.13.1 Astellas Pharma Company Information

13.13.2 Astellas Pharma Uterine Fibroid Embolization Device Product Offered

13.13.3 Astellas Pharma Uterine Fibroid Embolization Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Astellas Pharma Main Business Overview

13.13.5 Astellas Pharma Latest Developments

13.14 Nippon Kayaku

13.14.1 Nippon Kayaku Company Information

13.14.2 Nippon Kayaku Uterine Fibroid Embolization Device Product Offered

13.14.3 Nippon Kayaku Uterine Fibroid Embolization Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Nippon Kayaku Main Business Overview

13.14.5 Nippon Kayaku Latest Developments

13.15 Pfizer

13.15.1 Pfizer Company Information

13.15.2 Pfizer Uterine Fibroid Embolization Device Product Offered

13.15.3 Pfizer Uterine Fibroid Embolization Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Pfizer Main Business Overview

13.15.5 Pfizer Latest Developments

14 Research Findings and Conclusion

Table 1. Uterine Fibroid Embolization Device Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Uterine Fibroid Embolization Device Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Gelatin Sponge

Table 4. Major Players of Polyvinyl Alcohol ( PVA ) Particles

Table 5. Major Players of Trisacryl Gelatin Microspheres ( TAGM )

Table 6. Major Players of Polymethyl Methacrylate ( PMMA ) Microspheres

Table 7. Global Uterine Fibroid Embolization Device Sales by Type (2017-2022) & (K Units)

Table 8. Global Uterine Fibroid Embolization Device Sales Market Share by Type (2017-2022)

Table 9. Global Uterine Fibroid Embolization Device Revenue by Type (2017-2022) & ($ million)

Table 10. Global Uterine Fibroid Embolization Device Revenue Market Share by Type (2017-2022)

Table 11. Global Uterine Fibroid Embolization Device Sale Price by Type (2017-2022) & (US$/Unit)

Table 12. Global Uterine Fibroid Embolization Device Sales by Application (2017-2022) & (K Units)

Table 13. Global Uterine Fibroid Embolization Device Sales Market Share by Application (2017-2022)

Table 14. Global Uterine Fibroid Embolization Device Revenue by Application (2017-2022)

Table 15. Global Uterine Fibroid Embolization Device Revenue Market Share by Application (2017-2022)

Table 16. Global Uterine Fibroid Embolization Device Sale Price by Application (2017-2022) & (US$/Unit)

Table 17. Global Uterine Fibroid Embolization Device Sales by Company (2020-2022) & (K Units)

Table 18. Global Uterine Fibroid Embolization Device Sales Market Share by Company (2020-2022)

Table 19. Global Uterine Fibroid Embolization Device Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Uterine Fibroid Embolization Device Revenue Market Share by Company (2020-2022)

Table 21. Global Uterine Fibroid Embolization Device Sale Price by Company (2020-2022) & (US$/Unit)

Table 22. Key Manufacturers Uterine Fibroid Embolization Device Producing Area Distribution and Sales Area

Table 23. Players Uterine Fibroid Embolization Device Products Offered

Table 24. Uterine Fibroid Embolization Device Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Uterine Fibroid Embolization Device Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Uterine Fibroid Embolization Device Sales Market Share Geographic Region (2017-2022)

Table 29. Global Uterine Fibroid Embolization Device Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Uterine Fibroid Embolization Device Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Uterine Fibroid Embolization Device Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Uterine Fibroid Embolization Device Sales Market Share by Country/Region (2017-2022)

Table 33. Global Uterine Fibroid Embolization Device Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Uterine Fibroid Embolization Device Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Uterine Fibroid Embolization Device Sales by Country (2017-2022) & (K Units)

Table 36. Americas Uterine Fibroid Embolization Device Sales Market Share by Country (2017-2022)

Table 37. Americas Uterine Fibroid Embolization Device Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Uterine Fibroid Embolization Device Revenue Market Share by Country (2017-2022)

Table 39. Americas Uterine Fibroid Embolization Device Sales by Type (2017-2022) & (K Units)

Table 40. Americas Uterine Fibroid Embolization Device Sales Market Share by Type (2017-2022)

Table 41. Americas Uterine Fibroid Embolization Device Sales by Application (2017-2022) & (K Units)

Table 42. Americas Uterine Fibroid Embolization Device Sales Market Share by Application (2017-2022)

Table 43. APAC Uterine Fibroid Embolization Device Sales by Region (2017-2022) & (K Units)

Table 44. APAC Uterine Fibroid Embolization Device Sales Market Share by Region (2017-2022)

Table 45. APAC Uterine Fibroid Embolization Device Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Uterine Fibroid Embolization Device Revenue Market Share by Region (2017-2022)

Table 47. APAC Uterine Fibroid Embolization Device Sales by Type (2017-2022) & (K Units)

Table 48. APAC Uterine Fibroid Embolization Device Sales Market Share by Type (2017-2022)

Table 49. APAC Uterine Fibroid Embolization Device Sales by Application (2017-2022) & (K Units)

Table 50. APAC Uterine Fibroid Embolization Device Sales Market Share by Application (2017-2022)

Table 51. Europe Uterine Fibroid Embolization Device Sales by Country (2017-2022) & (K Units)

Table 52. Europe Uterine Fibroid Embolization Device Sales Market Share by Country (2017-2022)

Table 53. Europe Uterine Fibroid Embolization Device Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Uterine Fibroid Embolization Device Revenue Market Share by Country (2017-2022)

Table 55. Europe Uterine Fibroid Embolization Device Sales by Type (2017-2022) & (K Units)

Table 56. Europe Uterine Fibroid Embolization Device Sales Market Share by Type (2017-2022)

Table 57. Europe Uterine Fibroid Embolization Device Sales by Application (2017-2022) & (K Units)

Table 58. Europe Uterine Fibroid Embolization Device Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Uterine Fibroid Embolization Device Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Uterine Fibroid Embolization Device Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Uterine Fibroid Embolization Device Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Uterine Fibroid Embolization Device Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Uterine Fibroid Embolization Device Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Uterine Fibroid Embolization Device Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Uterine Fibroid Embolization Device Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Uterine Fibroid Embolization Device Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Uterine Fibroid Embolization Device

Table 68. Key Market Challenges & Risks of Uterine Fibroid Embolization Device

Table 69. Key Industry Trends of Uterine Fibroid Embolization Device

Table 70. Uterine Fibroid Embolization Device Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Uterine Fibroid Embolization Device Distributors List

Table 73. Uterine Fibroid Embolization Device Customer List

Table 74. Global Uterine Fibroid Embolization Device Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Uterine Fibroid Embolization Device Sales Market Forecast by Region

Table 76. Global Uterine Fibroid Embolization Device Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Uterine Fibroid Embolization Device Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Uterine Fibroid Embolization Device Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Uterine Fibroid Embolization Device Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Uterine Fibroid Embolization Device Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Uterine Fibroid Embolization Device Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Uterine Fibroid Embolization Device Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Uterine Fibroid Embolization Device Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Uterine Fibroid Embolization Device Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Uterine Fibroid Embolization Device Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Uterine Fibroid Embolization Device Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Uterine Fibroid Embolization Device Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Uterine Fibroid Embolization Device Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Uterine Fibroid Embolization Device Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Uterine Fibroid Embolization Device Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Uterine Fibroid Embolization Device Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Uterine Fibroid Embolization Device Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Uterine Fibroid Embolization Device Revenue Market Share Forecast by Application (2023-2028)

Table 94. Boston Scientific Corporation Basic Information, Uterine Fibroid Embolization Device Manufacturing Base, Sales Area and Its Competitors

Table 95. Boston Scientific Corporation Uterine Fibroid Embolization Device Product Offered

Table 96. Boston Scientific Corporation Uterine Fibroid Embolization Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 97. Boston Scientific Corporation Main Business

Table 98. Boston Scientific Corporation Latest Developments

Table 99. Merit Medical Systems Basic Information, Uterine Fibroid Embolization Device Manufacturing Base, Sales Area and Its Competitors

Table 100. Merit Medical Systems Uterine Fibroid Embolization Device Product Offered

Table 101. Merit Medical Systems Uterine Fibroid Embolization Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 102. Merit Medical Systems Main Business

Table 103. Merit Medical Systems Latest Developments

Table 104. BioSpace Basic Information, Uterine Fibroid Embolization Device Manufacturing Base, Sales Area and Its Competitors

Table 105. BioSpace Uterine Fibroid Embolization Device Product Offered

Table 106. BioSpace Uterine Fibroid Embolization Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 107. BioSpace Main Business

Table 108. BioSpace Latest Developments

Table 109. Hologic, Inc. Basic Information, Uterine Fibroid Embolization Device Manufacturing Base, Sales Area and Its Competitors

Table 110. Hologic, Inc. Uterine Fibroid Embolization Device Product Offered

Table 111. Hologic, Inc. Uterine Fibroid Embolization Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 112. Hologic, Inc. Main Business

Table 113. Hologic, Inc. Latest Developments

Table 114. Cook Medical Basic Information, Uterine Fibroid Embolization Device Manufacturing Base, Sales Area and Its Competitors

Table 115. Cook Medical Uterine Fibroid Embolization Device Product Offered

Table 116. Cook Medical Uterine Fibroid Embolization Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 117. Cook Medical Main Business

Table 118. Cook Medical Latest Developments

Table 119. Ferring B.V. Basic Information, Uterine Fibroid Embolization Device Manufacturing Base, Sales Area and Its Competitors

Table 120. Ferring B.V. Uterine Fibroid Embolization Device Product Offered

Table 121. Ferring B.V. Uterine Fibroid Embolization Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 122. Ferring B.V. Main Business

Table 123. Ferring B.V. Latest Developments

Table 124. Smith+Nephew Basic Information, Uterine Fibroid Embolization Device Manufacturing Base, Sales Area and Its Competitors

Table 125. Smith+Nephew Uterine Fibroid Embolization Device Product Offered

Table 126. Smith+Nephew Uterine Fibroid Embolization Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 127. Smith+Nephew Main Business

Table 128. Smith+Nephew Latest Developments

Table 129. CooperSurgical, Inc. Basic Information, Uterine Fibroid Embolization Device Manufacturing Base, Sales Area and Its Competitors

Table 130. CooperSurgical, Inc. Uterine Fibroid Embolization Device Product Offered

Table 131. CooperSurgical, Inc. Uterine Fibroid Embolization Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 132. CooperSurgical, Inc. Main Business

Table 133. CooperSurgical, Inc. Latest Developments

Table 134. Aetna Better Health of Pennsylvania Basic Information, Uterine Fibroid Embolization Device Manufacturing Base, Sales Area and Its Competitors

Table 135. Aetna Better Health of Pennsylvania Uterine Fibroid Embolization Device Product Offered

Table 136. Aetna Better Health of Pennsylvania Uterine Fibroid Embolization Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 137. Aetna Better Health of Pennsylvania Main Business

Table 138. Aetna Better Health of Pennsylvania Latest Developments

Table 139. Ethicon US, LLC Basic Information, Uterine Fibroid Embolization Device Manufacturing Base, Sales Area and Its Competitors

Table 140. Ethicon US, LLC Uterine Fibroid Embolization Device Product Offered

Table 141. Ethicon US, LLC Uterine Fibroid Embolization Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 142. Ethicon US, LLC Main Business

Table 143. Ethicon US, LLC Latest Developments

Table 144. Olympus America Basic Information, Uterine Fibroid Embolization Device Manufacturing Base, Sales Area and Its Competitors

Table 145. Olympus America Uterine Fibroid Embolization Device Product Offered

Table 146. Olympus America Uterine Fibroid Embolization Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 147. Olympus America Main Business

Table 148. Olympus America Latest Developments

Table 149. Stryker Basic Information, Uterine Fibroid Embolization Device Manufacturing Base, Sales Area and Its Competitors

Table 150. Stryker Uterine Fibroid Embolization Device Product Offered

Table 151. Stryker Uterine Fibroid Embolization Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 152. Stryker Main Business

Table 153. Stryker Latest Developments

Table 154. Astellas Pharma Basic Information, Uterine Fibroid Embolization Device Manufacturing Base, Sales Area and Its Competitors

Table 155. Astellas Pharma Uterine Fibroid Embolization Device Product Offered

Table 156. Astellas Pharma Uterine Fibroid Embolization Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 157. Astellas Pharma Main Business

Table 158. Astellas Pharma Latest Developments

Table 159. Nippon Kayaku Basic Information, Uterine Fibroid Embolization Device Manufacturing Base, Sales Area and Its Competitors

Table 160. Nippon Kayaku Uterine Fibroid Embolization Device Product Offered

Table 161. Nippon Kayaku Uterine Fibroid Embolization Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 162. Nippon Kayaku Main Business

Table 163. Nippon Kayaku Latest Developments

Table 164. Pfizer Basic Information, Uterine Fibroid Embolization Device Manufacturing Base, Sales Area and Its Competitors

Table 165. Pfizer Uterine Fibroid Embolization Device Product Offered

Table 166. Pfizer Uterine Fibroid Embolization Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 167. Pfizer Main Business

Table 168. Pfizer Latest Developments

List of Figures

Figure 1. Picture of Uterine Fibroid Embolization Device

Figure 2. Uterine Fibroid Embolization Device Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Uterine Fibroid Embolization Device Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Uterine Fibroid Embolization Device Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Uterine Fibroid Embolization Device Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Gelatin Sponge

Figure 10. Product Picture of Polyvinyl Alcohol ( PVA ) Particles

Figure 11. Product Picture of Trisacryl Gelatin Microspheres ( TAGM )

Figure 12. Product Picture of Polymethyl Methacrylate ( PMMA ) Microspheres

Figure 13. Global Uterine Fibroid Embolization Device Sales Market Share by Type in 2021

Figure 14. Global Uterine Fibroid Embolization Device Revenue Market Share by Type (2017-2022)

Figure 15. Uterine Fibroid Embolization Device Consumed in Hospitals

Figure 16. Global Uterine Fibroid Embolization Device Market: Hospitals (2017-2022) & (K Units)

Figure 17. Uterine Fibroid Embolization Device Consumed in Clinics

Figure 18. Global Uterine Fibroid Embolization Device Market: Clinics (2017-2022) & (K Units)

Figure 19. Global Uterine Fibroid Embolization Device Sales Market Share by Application (2017-2022)

Figure 20. Global Uterine Fibroid Embolization Device Revenue Market Share by Application in 2021

Figure 21. Uterine Fibroid Embolization Device Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Uterine Fibroid Embolization Device Revenue Market Share by Company in 2021

Figure 23. Global Uterine Fibroid Embolization Device Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Uterine Fibroid Embolization Device Revenue Market Share by Geographic Region in 2021

Figure 25. Global Uterine Fibroid Embolization Device Sales Market Share by Region (2017-2022)

Figure 26. Global Uterine Fibroid Embolization Device Revenue Market Share by Country/Region in 2021

Figure 27. Americas Uterine Fibroid Embolization Device Sales 2017-2022 (K Units)

Figure 28. Americas Uterine Fibroid Embolization Device Revenue 2017-2022 ($ Millions)

Figure 29. APAC Uterine Fibroid Embolization Device Sales 2017-2022 (K Units)

Figure 30. APAC Uterine Fibroid Embolization Device Revenue 2017-2022 ($ Millions)

Figure 31. Europe Uterine Fibroid Embolization Device Sales 2017-2022 (K Units)

Figure 32. Europe Uterine Fibroid Embolization Device Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Uterine Fibroid Embolization Device Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Uterine Fibroid Embolization Device Revenue 2017-2022 ($ Millions)

Figure 35. Americas Uterine Fibroid Embolization Device Sales Market Share by Country in 2021

Figure 36. Americas Uterine Fibroid Embolization Device Revenue Market Share by Country in 2021

Figure 37. United States Uterine Fibroid Embolization Device Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Uterine Fibroid Embolization Device Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Uterine Fibroid Embolization Device Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Uterine Fibroid Embolization Device Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Uterine Fibroid Embolization Device Sales Market Share by Region in 2021

Figure 42. APAC Uterine Fibroid Embolization Device Revenue Market Share by Regions in 2021

Figure 43. China Uterine Fibroid Embolization Device Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Uterine Fibroid Embolization Device Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Uterine Fibroid Embolization Device Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Uterine Fibroid Embolization Device Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Uterine Fibroid Embolization Device Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Uterine Fibroid Embolization Device Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Uterine Fibroid Embolization Device Sales Market Share by Country in 2021

Figure 50. Europe Uterine Fibroid Embolization Device Revenue Market Share by Country in 2021

Figure 51. Germany Uterine Fibroid Embolization Device Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Uterine Fibroid Embolization Device Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Uterine Fibroid Embolization Device Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Uterine Fibroid Embolization Device Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Uterine Fibroid Embolization Device Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Uterine Fibroid Embolization Device Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Uterine Fibroid Embolization Device Revenue Market Share by Country in 2021

Figure 58. Egypt Uterine Fibroid Embolization Device Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Uterine Fibroid Embolization Device Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Uterine Fibroid Embolization Device Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Uterine Fibroid Embolization Device Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Uterine Fibroid Embolization Device Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Uterine Fibroid Embolization Device in 2021

Figure 64. Manufacturing Process Analysis of Uterine Fibroid Embolization Device

Figure 65. Industry Chain Structure of Uterine Fibroid Embolization Device

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles